AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
JAVMA news
Webinar explains federal guidance on manufacturing of animal cells and tissues
The Food and Drug Administration posted a prerecorded webinar this fall explaining draft guidance documents on good manufacturing practices and donor…
JAVMA news
Racing to save humans through animal research
Veterinary researchers are improving our understanding of the SARS-CoV-2 virus, interspecies transmission, and a host of other public and animal…
JAVMA news
NIH funds development of novel Lyme disease vaccine
The grant is funding the efforts of tick immunobiologist Utpal Pal, PhD, to adapt the rabies vaccination platform to stimulate production of…
JAVMA news
Groups provide new guidance on antimicrobials
The AVMA, Canadian VMA, and Federation of Veterinarians of Europe are calling for continuous monitoring of antimicrobial use and resistance at a…
JAVMA news
The continuing conundrum of feline injection-site sarcomas
Veterinarians would much rather talk with cat owners about all the advantages of vaccination for cats rather than the extremely rare occurrence of…
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
AAHA releases new guidelines on canine vaccination
The American Animal Hospital Association announced Sept. 5 that it has released new guidelines on canine vaccination.
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
Drug's sale halted over arsenic concerns
A pharmaceutical company planned to halt sales of a drug used to treat a parasitic disease and increase growth in chickens after it was found that use…
JAVMA news
Extralabel drug substitution runs afoul of law
Extralabel use of drugs can give veterinarians effective options in treating patients, but there are limitations veterinarians should be aware of when…